Renal Cancer - Results from #100

Comparative analysis of trifecta and pentafecta outcomes in T1a and T1b renal tumors following robotic partial nephrectomy: a retrospective study. February 21, 2025

Oncologists' and urologists' preferences for adjuvant therapy in renal cell carcinoma: a discrete-choice experiment. February 21, 2025

The genomic landscape of metastatic clear-cell renal cell carcinoma and its prognostic value: a comprehensive analysis of a large real-world clinico-genomic database. February 20, 2025

Navigating advanced renal cell carcinoma in the era of artificial intelligence. February 20, 2025

Laparoscopic surgery for renal tumors in patients aged 85 years and older. February 19, 2025

Differentiating between renal medullary and clear cell renal carcinoma with a machine learning radiomics approach. February 19, 2025

Time trend and age-period-cohort effect on kidney cancer mortality in spain, 1983-2022. February 18, 2025

Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma. February 17, 2025

Characteristics of patients with metastatic renal cell carcinoma who do not respond to axitinib treatment. February 17, 2025

[89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial. February 15, 2025

Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 study. February 15, 2025

A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma. February 14, 2025

Pathogenicity of germline VHL variants is associated with renal cell carcinoma size in von Hippel-Lindau disease. February 14, 2025

Management of oligometastatic and oligoprogressive renal cell carcinoma: an updated review. February 13, 2025

Patient preferences for adjuvant therapy in renal cell carcinoma: a discrete-choice experiment. February 13, 2025

Organoids as Sophisticated Tools for Renal Cancer Research: Extensive Applications and Promising Prospects. February 12, 2025

Belzutifan for the treatment of renal cell carcinoma. February 12, 2025

Oncogenic TFE3 fusions drive OXPHOS and confer metabolic vulnerabilities in translocation renal cell carcinoma. February 11, 2025

A Fully Automated Artificial Intelligence-Based Approach to Predict Renal Function after Radical or Partial Nephrectomy. February 11, 2025

Towards a Consensus on the Management of Metastatic Renal Cell Carcinoma: Insights from a European Delphi Study. February 11, 2025

Page 6 of 466